Diabetes

Senseonics Stock: Overvalued and Struggling to Compete

Whenever one of your friends starts asking certain questions, you know what’s coming next. “Wouldn’t you rather work a lot less than you do?” “Could you use more money?” “Are you worried about your financial future?” These are all primer questions leading up to a pitch for whatever multi-level marketing Kool-Aid was pitched to them […]

Dexcom Stock: How Much Growth is Left?

“I never realized that I loved hiking,” says a moderately attractive woman named Abby who breaks into tears over the thought of her newly found hobby. This woman has clearly never encountered a tick in her life, but if she did, the tick probably wouldn’t find her blood to be that tasty. You see, Nancy […]

Lux Capital Launches Digital Health Solutions ETF: EKG

When it comes to getting the most diversification bang for your buck, it’s hard to beat exchange traded funds (ETFs) which typically offer the performance of whatever index they’re tracking for a reasonable expense ratio. While ARK Invest made waves by releasing active ETFs that attempted to beat the markets, your typical ETF simply tracks […]

A Large-Cap Diabetes Stock That’s Growing Like Mad

It’s been quite entertaining lately to watch some Americans waddle around whinging about how oppressed they are, when it’s apparent that none of them have ever visited an actual dictatorship. In many of the 50 remaining dictatorships on this planet, people often starve, yet in the U.S. there seems to be too much food available. […]

Livongo IPO: An AI Stock for Managing Chronic Diseases

We’re halfway through 2019 and we’ve seen a ton of high-profile startups IPO this year. However, few of those joining the ranks of public companies represent a pure play in the sort of emerging technologies that we cover here at Nanalyze. That’s especially been the case with companies where artificial intelligence is at the core […]

A Bionic Pancreas that Uses Machine Learning for Good

Former Vice President Al Gore was back in the news this month, raising millions for a new campaign. No, not the one crowded with 22 candidates and counting. His Generation Investment Management firm just raised $1 billion for what those who know anything about impact investing might call a do-gooder fund. Socially responsible investing, which […]

An Artificial Pancreas for Diabetics is Almost Here

If you’ve ever taken an introductory cultural anthropology class, you might recall reading a paper on “Body Ritual among the Nacirema.” Written in 1956, it’s an account of an anthropologist who visits a tribe and observes all kinds of weird behavior – like medicine men who jab coated needles into the flesh of the natives. […]

When Will There Be a Cure for Diabetes?

Diabetes doesn’t cause nearly as much of a stir in the media compared to HIV or cancer, but a few well-known names are associated with the disease – Halle Berry, Tom Hanks, and Paula Deen. And who doesn’t love that Food Network maven and American celebrity chef? Scandals aside, diabetes comes in two versions – Type […]

Insulin Pump Company Cellnovo Has an IPO

This past week, Google (NASDAQ:GOOGL) announced their intention to work with Dexcom (NASDAQ:DXCM) to create a glucose monitor that is easy to afford and maintain and which does not involve the need for a blood sample. For people that suffer from diabetes, monitoring their glucose levels has been a painful practice that involves pricking one’s finger and […]

Intarcia Therapeutics Revolutionizes Diabetes Treatment

The biotech industry has been kind to investors over the past year with the SPDR S&P Biotech ETF (XBI) up over +75% in the past year compared to an +8.7% increase over the same time frame for the S&P 500. Biotech IPOs have been even hotter with 2014 setting an all-time record both in the number of […]